Agilent Acquires Luxcel Biosciences

Agilent stock is up heading into the announcement that the company acquired Luxcel Biosciences. I think the stock has run up too far to be a good entry right now.

Agilent Technologies has acquired Luxcel Biosciences, a developer of real-time fluorescence plate-reader based from vitro cell assay kits. This acquisition expands Agilent's cell evaluation portfolio with the inclusion of easy-to-use assay kits which are compatible with industry standard plate-readers.

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Author: Lance Jepsen

For ethical purposes, I try not to hold any position in any stock I profile on GuerillaStockTrading.com unless specifically stated in the article. Owner of GuerillaStockTrading.com. Seasoned entrepreneur, investor, and writer. I love God, family, country, stock trading, economics, and helping people learn how to trade.

Leave a Reply

Sending